Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the Literature

We report the second case of ETV6-ACSL6 associated myeloproliferative neoplasm that has received a full course of imatinib therapy. The patient was a 51-year-old previously healthy man who presented with three months of worsening dyspnea and was found to have a white count of 216,000/cmm, of which 8...

Full description

Saved in:
Bibliographic Details
Main Authors: Javier De Luca-Johnson, Jose I. Ruades Ninfea, Lauren Pearson, Joanna Conant, Ronald Bryant, Neil A. Zakai, Mary E. Tang
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Case Reports in Medicine
Online Access:http://dx.doi.org/10.1155/2016/8324791
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552718312407040
author Javier De Luca-Johnson
Jose I. Ruades Ninfea
Lauren Pearson
Joanna Conant
Ronald Bryant
Neil A. Zakai
Mary E. Tang
author_facet Javier De Luca-Johnson
Jose I. Ruades Ninfea
Lauren Pearson
Joanna Conant
Ronald Bryant
Neil A. Zakai
Mary E. Tang
author_sort Javier De Luca-Johnson
collection DOAJ
description We report the second case of ETV6-ACSL6 associated myeloproliferative neoplasm that has received a full course of imatinib therapy. The patient was a 51-year-old previously healthy man who presented with three months of worsening dyspnea and was found to have a white count of 216,000/cmm, of which 84% were eosinophil lineage. Cytogenetic analysis revealed a t(5;12)(q31~33;p13). FISH was negative for PDGFRB rearrangement but additional FISH testing demonstrated an ACSL6 rearrangement. ETV6-ACSL6 gene fusion is a rare abnormality that most often presents as a myeloproliferative-type disorder with prominent eosinophilia or basophilia. Review of the literature yielded a total of 11 previous cases. This gene fusion results in a t(5;12)(q31~33;p13) that mimics the t(5;12) found in ETV6-PDGFRB neoplasms. Identification of the fusion genes involved in t(5;12) in eosinophilia-associated myeloproliferative disorders is crucial to direct an effective treatment plan. In particular, while tyrosine kinase inhibitor therapy is effective in patients with PDGFRB rearrangement, there is little information on imatinib efficacy in patients with ETV6-ACSL6 gene fusion. Our patient was found to be nonresponsive to imatinib therapy.
format Article
id doaj-art-7861242358aa47eb844ded7747371d4e
institution Kabale University
issn 1687-9627
1687-9635
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Case Reports in Medicine
spelling doaj-art-7861242358aa47eb844ded7747371d4e2025-02-03T05:58:05ZengWileyCase Reports in Medicine1687-96271687-96352016-01-01201610.1155/2016/83247918324791Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the LiteratureJavier De Luca-Johnson0Jose I. Ruades Ninfea1Lauren Pearson2Joanna Conant3Ronald Bryant4Neil A. Zakai5Mary E. Tang6Department of Pathology and Laboratory Medicine, University of Vermont Medical Center, 89 Beaumont Avenue, Courtyard at Given S269, Burlington, VT 05405, USADepartment of Medicine, Division of Hematology and Oncology, University of Vermont Medical Center, 89 Beaumont Avenue, Given E-214-UVM363, Burlington, VT 05405, USADepartment of Pathology and Laboratory Medicine, University of Vermont Medical Center, 89 Beaumont Avenue, Courtyard at Given S269, Burlington, VT 05405, USADepartment of Pathology and Laboratory Medicine, University of Vermont Medical Center, 89 Beaumont Avenue, Courtyard at Given S269, Burlington, VT 05405, USADepartment of Pathology and Laboratory Medicine, University of Vermont Medical Center, 89 Beaumont Avenue, Courtyard at Given S269, Burlington, VT 05405, USADepartment of Pathology and Laboratory Medicine, University of Vermont Medical Center, 89 Beaumont Avenue, Courtyard at Given S269, Burlington, VT 05405, USADepartment of Pathology and Laboratory Medicine, University of Vermont Medical Center, 89 Beaumont Avenue, Courtyard at Given S269, Burlington, VT 05405, USAWe report the second case of ETV6-ACSL6 associated myeloproliferative neoplasm that has received a full course of imatinib therapy. The patient was a 51-year-old previously healthy man who presented with three months of worsening dyspnea and was found to have a white count of 216,000/cmm, of which 84% were eosinophil lineage. Cytogenetic analysis revealed a t(5;12)(q31~33;p13). FISH was negative for PDGFRB rearrangement but additional FISH testing demonstrated an ACSL6 rearrangement. ETV6-ACSL6 gene fusion is a rare abnormality that most often presents as a myeloproliferative-type disorder with prominent eosinophilia or basophilia. Review of the literature yielded a total of 11 previous cases. This gene fusion results in a t(5;12)(q31~33;p13) that mimics the t(5;12) found in ETV6-PDGFRB neoplasms. Identification of the fusion genes involved in t(5;12) in eosinophilia-associated myeloproliferative disorders is crucial to direct an effective treatment plan. In particular, while tyrosine kinase inhibitor therapy is effective in patients with PDGFRB rearrangement, there is little information on imatinib efficacy in patients with ETV6-ACSL6 gene fusion. Our patient was found to be nonresponsive to imatinib therapy.http://dx.doi.org/10.1155/2016/8324791
spellingShingle Javier De Luca-Johnson
Jose I. Ruades Ninfea
Lauren Pearson
Joanna Conant
Ronald Bryant
Neil A. Zakai
Mary E. Tang
Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the Literature
Case Reports in Medicine
title Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the Literature
title_full Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the Literature
title_fullStr Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the Literature
title_full_unstemmed Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the Literature
title_short Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the Literature
title_sort myeloid neoplasms with t 5 12 and etv6 acsl6 gene fusion potential mimickers of myeloid neoplasm with pdgfrb rearrangement case report with imatinib therapy and review of the literature
url http://dx.doi.org/10.1155/2016/8324791
work_keys_str_mv AT javierdelucajohnson myeloidneoplasmswitht512andetv6acsl6genefusionpotentialmimickersofmyeloidneoplasmwithpdgfrbrearrangementcasereportwithimatinibtherapyandreviewoftheliterature
AT joseiruadesninfea myeloidneoplasmswitht512andetv6acsl6genefusionpotentialmimickersofmyeloidneoplasmwithpdgfrbrearrangementcasereportwithimatinibtherapyandreviewoftheliterature
AT laurenpearson myeloidneoplasmswitht512andetv6acsl6genefusionpotentialmimickersofmyeloidneoplasmwithpdgfrbrearrangementcasereportwithimatinibtherapyandreviewoftheliterature
AT joannaconant myeloidneoplasmswitht512andetv6acsl6genefusionpotentialmimickersofmyeloidneoplasmwithpdgfrbrearrangementcasereportwithimatinibtherapyandreviewoftheliterature
AT ronaldbryant myeloidneoplasmswitht512andetv6acsl6genefusionpotentialmimickersofmyeloidneoplasmwithpdgfrbrearrangementcasereportwithimatinibtherapyandreviewoftheliterature
AT neilazakai myeloidneoplasmswitht512andetv6acsl6genefusionpotentialmimickersofmyeloidneoplasmwithpdgfrbrearrangementcasereportwithimatinibtherapyandreviewoftheliterature
AT maryetang myeloidneoplasmswitht512andetv6acsl6genefusionpotentialmimickersofmyeloidneoplasmwithpdgfrbrearrangementcasereportwithimatinibtherapyandreviewoftheliterature